Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS (RMU), RMP, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Rheumatologist
MBBS, FCPS (MEDICINE), FCPS (RHEUMATOLOGY)
Internal Medicine Specialist
MBBS, MCPS
General Physician
M.B.B.S., Certificate in Diabetes, Certified in Family Medicine, Certified Bls-American Heart Association
General Physician
M.B.B.S., Certificate in Diabetes, Certified in Family Medicine, Certified Bls-American Heart Association
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures